Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance

There are limited data on post-transplant lymphoproliferative disorder (PTLD) in the era of positron emission tomography (PET) and rituximab (R). Furthermore, there is limited data on the risk of graft rejection with modern practices in reduction in immunosuppression (RIS). We studied 91 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyle, Stephen, Tobin, Joshua W. D., Perram, Jacinta, Hamad, Nada, Gullapalli, Veena, Barraclough, Allison, Singaraveloo, Lydia, Han, Min-Hi, Blennerhassett, Richard, Nelson, Niles, Johnston, Anna M., Talaulikar, Dipti, Karpe, Krishna, Bhattacharyya, Abir, Cheah, Chan Yoon, Subramoniapillai, Elango, Bokhari, Waqas, Lee, Cindy, Hawkes, Eliza A., Jabbour, Andrew, Strasser, Simone I., Chadban, Steven J., Brown, Christina, Mollee, Peter, Hapgood, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505336/
https://www.ncbi.nlm.nih.gov/pubmed/34651103
http://dx.doi.org/10.1097/HS9.0000000000000648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505336/
https://www.ncbi.nlm.nih.gov/pubmed/34651103
http://dx.doi.org/10.1097/HS9.0000000000000648

Ejemplares similares